Immunitybio Inc (IBRX) is around the middle of the Biotechnology industry according to InvestorsObserver. IBRX received an overall rating of 52, which means that it scores higher than 52 percent of all stocks. Immunitybio Inc also achieved a score of 51 in the Biotechnology industry, putting it above 51 percent of Biotechnology stocks. Biotechnology is ranked 14 out of the 148 industries.
IBRX has an Overall Score of 52. Find out what this means to you and get the rest of the rankings on IBRX!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 52 would rank higher than 52 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Immunitybio Inc Stock Today?
Immunitybio Inc (IBRX) stock is trading at $5.04 as of 12:55 PM on Tuesday, Mar 5, a decline of -$0.03, or -0.59% from the previous closing price of $5.07. The stock has traded between $4.95 and $5.33 so far today. Volume today is below average. So far 2,306,452 shares have traded compared to average volume of 4,236,446 shares.
Click Here to get the full Stock Report for Immunitybio Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
